26 October 2020 To: The President The Stock Exchange of Thailand Re: Q3-2020 Operating Results We, Delta Electronics (Thailand) Public Company Limited (the “Company”) would like to notify the

27 April 2021 To: The President The Stock Exchange of Thailand Re: Q1-2021 Operating Results We, Delta Electronics (Thailand) Public Company Limited (the “Company”) would like to notify the Company’s

27 April 2020 To: The President The Stock Exchange of Thailand Re: Q1-2020 Operating Results We, Delta Electronics (Thailand) Public Company Limited (the “Company”) would like to notify the Company’s

Manager The Stock Exchange of Thailand According to the resolution of the meeting of the Board of Directors No. 3/2020 of Wattanapat Hospital Trang Public Company Limited (“the Company”) held on 13 May 2020

www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the

the Board of Directors approving the capital decrease, the capital increase, the allotment of newly issued ordinary shares to investors in private placement, the acquisition of assets and convening the

decrease, the capital increase, the allotment of newly issued ordinary shares to investors in private placement, the acquisition of assets and convening the Extraordinary General Meeting of the Shareholders

and Managing Director, said that the Stock Exchange of Thailand (SET) is intend to develop the “Digital Gateway” to complete the digital capital market covering from opening new accounts, providing

% 4.6% -1.4% 3.9% 6.0% -2.1% Stock Gain/(Loss) & NRV -149 -425 -65% -233 -36% -382 -458 -17% Adjusted EBITDA(1) 286 653 -56% 444 -36% 730 998 -27% Adjusted EBITDA Margin (%) 6.8% 13.5% -6.7% 9.6% -2.8

million, respectively. The decrease was primarily due to the increase of Medical personnel to support its expansion included administrative expenses to prepare for listing on the Stock Exchange of Thailand